According to the in vitro study conducted by Kuzmina et al. [87], mutation Pro-to-Arg (BJ.1, XBB and BS.1) can enhance the cell fusion and production of syncytia, induced by the S protein, which is typically seen in COVID-19 patients who have developed severe chronic respiratory disease [88]. The gene discussed is PROS1; the disease is COVID-19.